Bionano Genomics (BNGO) Profit After Tax (2017 - 2026)

Bionano Genomics (BNGO) has 10 years of Profit After Tax data on file, last reported at -$8.3 million in Q1 2026.

• For the quarter ending Q1 2026, Profit After Tax fell 167.67% year-over-year to -$8.3 million; the trailing twelve-month figure through Mar 2026 stood at -$31.6 million (up 62.25% YoY), and the FY2025 full-year result was -$26.4 million, up 76.44% from the prior year.
• Profit After Tax slipped to -$8.3 million in Q1 2026, from -$7.9 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of -$3.1 million in Q1 2025 to a low of -$112.6 million in Q3 2023.
• A 5-year average of -$30.1 million and a median of -$31.4 million in 2024 frame the typical range for Profit After Tax.
• Across the five-year window, Profit After Tax tumbled 253.88% in 2023 and surged 90.13% in 2025, its largest moves.
• Tracing BNGO's Profit After Tax over 5 years: stood at -$38.7 million in 2022, then fell by 13.48% to -$43.9 million in 2023, then jumped by 54.15% to -$20.1 million in 2024, then soared by 60.58% to -$7.9 million in 2025, then decreased by 4.66% to -$8.3 million in 2026.
• Business Quant data shows BNGO's Profit After Tax at -$8.3 million in Q1 2026, -$7.9 million in Q4 2025, and -$8.5 million in Q3 2025.